Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Head

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Acta Neurobiologiae Experimentalis|November 6, 2002
Neuropathology of variant Creutzfeldt-Jakob diseaseJames W Ironside, Mark W Head, Linda McCardle, et al.
The Journal of General Virology|December 3, 2010
Comparison of the level, distribution and form of disease-associated prion protein in variant and sporadic Creutzfeldt-Jakob diseased brain using conformation-dependent immunoassay and Western blotYoung Pyo Choi, Albrecht Gröner, James W Ironside, et al.
Brain Pathology (Zurich, Switzerland)|October 30, 2010
Correlation of polydispersed prion protein and characteristic pathology in the thalamus in variant Creutzfeldt-Jakob disease: implication of small oligomeric speciesYoung Pyo Choi, Albrecht Gröner, James W Ironside, et al.
Acta Neuropathologica|June 11, 2010
The application of in vitro cell-free conversion systems to human prion diseasesMichael Jones, Alexander H Peden, Mark W Head, et al.
The American Journal of Pathology|March 2, 2006
Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob diseaseAlexander H Peden, Diane L Ritchie, Mark W Head, et al.
Expert Opinion on Therapeutic Targets|January 24, 2003
The transmissible spongiform encephalopathies: pathogenic mechanisms and strategies for therapeutic interventionMark W Head, Christine F Farquhar, Neil A Mabbott, et al.
The American Journal of Pathology|October 5, 2014
Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytesYoung Pyo Choi, Mark W Head, James W Ironside, et al.
The Journal of Pathology. Clinical Research|April 18, 2018
Rapid amplification of prions from variant Creutzfeldt-Jakob disease cerebrospinal fluidMarcelo A Barria, Andrew Lee, Alison Je Green, et al.
The American Journal of Pathology|November 5, 2013
Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomesZuzana Krejciova, Paul De Sousa, Jean Manson, et al.
Expert Opinion on Medical Diagnostics|March 15, 2013
Advances in the development of a screening test for variant Creutzfeldt-Jakob diseaseAlexander H Peden, Mark W Head, Michael Jones, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Acta Neurobiologiae Experimentalis|November 6, 2002
Neuropathology of variant Creutzfeldt-Jakob diseaseJames W Ironside, Mark W Head, Linda McCardle, et al.
The Journal of General Virology|December 3, 2010
Comparison of the level, distribution and form of disease-associated prion protein in variant and sporadic Creutzfeldt-Jakob diseased brain using conformation-dependent immunoassay and Western blotYoung Pyo Choi, Albrecht Gröner, James W Ironside, et al.
Brain Pathology (Zurich, Switzerland)|October 30, 2010
Correlation of polydispersed prion protein and characteristic pathology in the thalamus in variant Creutzfeldt-Jakob disease: implication of small oligomeric speciesYoung Pyo Choi, Albrecht Gröner, James W Ironside, et al.
Acta Neuropathologica|June 11, 2010
The application of in vitro cell-free conversion systems to human prion diseasesMichael Jones, Alexander H Peden, Mark W Head, et al.
The American Journal of Pathology|March 2, 2006
Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob diseaseAlexander H Peden, Diane L Ritchie, Mark W Head, et al.
Expert Opinion on Therapeutic Targets|January 24, 2003
The transmissible spongiform encephalopathies: pathogenic mechanisms and strategies for therapeutic interventionMark W Head, Christine F Farquhar, Neil A Mabbott, et al.
The American Journal of Pathology|October 5, 2014
Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytesYoung Pyo Choi, Mark W Head, James W Ironside, et al.
The Journal of Pathology. Clinical Research|April 18, 2018
Rapid amplification of prions from variant Creutzfeldt-Jakob disease cerebrospinal fluidMarcelo A Barria, Andrew Lee, Alison Je Green, et al.
The American Journal of Pathology|November 5, 2013
Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomesZuzana Krejciova, Paul De Sousa, Jean Manson, et al.
Expert Opinion on Medical Diagnostics|March 15, 2013
Advances in the development of a screening test for variant Creutzfeldt-Jakob diseaseAlexander H Peden, Mark W Head, Michael Jones, et al.
Pageof 7